Skip to main content

Peptide Profile

Klotho

alpha-Klotho · a-Klotho · soluble Klotho · KL protein fragment

Klotho is an endogenous transmembrane protein and circulating hormone encoded by the KL gene, expressed primarily in kidney distal tubules and brain choroid plexus, that functions as a co-receptor for fibroblast growth factor 23…

Longevity & CellularNot EvaluatedResearch Only
Routes
subcutaneous, intravenous

Educational research information — not medical advice. Review primary sources and consult a qualified professional before any decision.

Educational research tools — not medical advice.

Overview

What Klotho is

About Klotho

Acts as a co-receptor for FGF23, regulating phosphate and vitamin D metabolism. As a circulating hormone, inhibits insulin/IGF-1 signaling to extend lifespan, activates Nrf2 antioxidant pathways, and suppresses TGF-β fibrotic signaling.

Klotho is an endogenous transmembrane protein and circulating hormone encoded by the KL gene, expressed primarily in kidney distal tubules and brain choroid plexus, that functions as a co-receptor for fibroblast growth factor 23 (FGF23) and as a systemic anti-aging regulatory factor; circulating alpha-klotho levels decline progressively with age and have been associated with accelerated aging phenotypes, cognitive decline, and increased cardiovascular mortality in large human cohort studies. Soluble klotho exerts pleiotropic protective effects including suppression of IGF-1 and Wnt signaling, reduction of oxidative stress and inflammation, regulation of calcium-phosphate homeostasis via FGF23 co-signaling, and neuroprotective effects relevant to brain aging; mouse models overexpressing klotho live approximately 30% longer while klotho-deficient mice develop premature aging syndromes, establishing it as a key longevity regulator in mammals. Human epidemiological and cohort data — including a systematic review and meta-analysis and a large PNAS cohort study — support significant associations between higher circulating klotho levels and better cognitive performance, lower dementia incidence, and reduced cardiovascular mortality, establishing klotho as a robust human biomarker of healthy aging. Exogenous klotho has no FDA approval and no human interventional trial data; while preclinical administration of recombinant klotho has shown promising anti-aging effects in animal models, the compound remains an active research target rather than an established therapeutic, and its use as an administered agent in humans is not supported by any published clinical evidence.

Klotho Benefits & Research Areas

neuroprotectioncardiovascular protectionanti-agingcognitive support
The Research

What the evidence says about Klotho

Research Evidence

based on 8 studies · most recent 2026

Regulatory Status

Availability Status
Research Only
FDA Status
Not Evaluated

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Research Sources

8 sources cited · 1 strong · 2 moderate · 5 weak

1 Meta-analysis · 2 Cohorts · 1 Review · 4 Animals

  • Klotho protein and cognitive function: a systematic review and meta-analysis

    Asian Journal of Psychiatry · 2025

    A systematic review and meta-analysis of studies totaling 6,645 participants found a significant positive correlation between klotho protein levels and cognitive function, with subgroup analyses confirming significance for α-klotho measured in serum and plasma, supporting klotho as a biomarker of cognitive aging and a candidate longevity-promoting target.

    Meta-analysisn=6,645StrongPMID 40048920
  • Association between soluble Klotho levels and calcification propensity T50 in patients with hemodialysis: a cross-sectional study.

    Sci Rep · 2026

    CohortModeratePMID 42332137
  • Klotho heterozygosity does not modify cognitive decline in APOE ε4 carriers: analysis of a large biobank cohort

    Proceedings of the National Academy of Sciences · 2025

    In a large biobank cohort of 320,861 participants, APOE ε4 homozygous carriers showed significantly greater cognitive decline than heterozygotes; klotho heterozygosity did not independently modify cognitive trajectories after controlling for APOE genotype, providing important context for interpreting klotho's cognitive benefits within the broader longevity genetic risk framework.

    Cohortn=320,861ModeratePMID 39903109
Show 5 more sources
  • VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in Mice.

    Life (Basel) · 2026

    # Summary Research found that VSIG4 expression increases during kidney aging in mice, with this process accelerated in type 2 diabetic mice compared to non-diabetic controls. This study demonstrated that urinary VSIG4 levels correlate strongly with kidney damage markers and may reflect age-related kidney changes, while klotho expression—a known marker of kidney aging—progressively declined over time.

    AnimalWeakPMID 42195288
  • Gene deletion of Klotho in the dentate gyrus does not affect the number of adult-born granule cells.

    Sci Rep · 2026

    # Summary Research found that removing the Klotho gene specifically in the dentate gyrus—a brain region involved in memory formation—did not alter the production or number of newly generated neurons in adult mice. This study demonstrated that despite Klotho's known roles in aging and neuroprotection, it is not required for maintaining the normal rate of adult neurogenesis in this particular brain structure.

    AnimalWeakPMID 42204218
  • Vitamin D attenuates Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and downregulates hepatic gluconeogenesis in obesity.

    J Nutr Biochem · 2026

    AnimalWeakPMID 42323099
  • Podocyte mPGES-2 Determines Renal Aging and Contributes to Senile Osteoporosis.

    Aging Cell · 2026

    AnimalWeakPMID 42347750
  • From Longevity Genetics to Precision Interventions: Integrating Nutrigenomics and Epigenetic Mechanisms of Ageing.

    Genes (Basel) · 2026

    ReviewTheoreticalPMID 42353842

Klotho Side Effects & Safety Considerations

Research-use compound with limited human data. Evidence strength varies — see the Evidence section.

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Frequently Asked Questions — Klotho

Klotho is an endogenous transmembrane protein and circulating hormone encoded by the KL gene, expressed primarily in kidney distal tubules and brain choroid plexus, that functions as a co-receptor for fibroblast growth factor 23 (FGF23) and as a systemic anti-aging regulatory factor; circulating alpha-klotho levels decline progressively with age and have been associated with accelerated aging phenotypes, cognitive decline, and increased cardiovascular mortality in large human cohort studies. Soluble klotho exerts pleiotropic protective effects including suppression of IGF-1 and Wnt signaling, reduction of oxidative stress and inflammation, regulation of calcium-phosphate homeostasis via FGF23 co-signaling, and neuroprotective effects relevant to brain aging; mouse models overexpressing klotho live approximately 30% longer while klotho-deficient mice develop premature aging syndromes, establishing it as a key longevity regulator in mammals.

neuroprotection, cardiovascular protection, anti-aging, cognitive support, anti-fibrotic.

Research on Klotho primarily documents effects related to neuroprotection and cardiovascular protection and anti-aging and cognitive support and anti-fibrotic. These are areas covered in preclinical and clinical literature — individual response varies and effects depend on context of use.

For Klotho, its FDA status is not evaluated by the FDA, and it is designated for research use only. Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

A systematic review and meta-analysis of studies totaling 6,645 participants found a significant positive correlation between klotho protein levels and cognitive function, with subgroup analyses confirming significance for α-klotho measured in serum and plasma, supporting klotho as a biomarker of cognitive aging and a candidate longevity-promoting target.

Access

How to get Klotho

Where to buy Klotho

Coverage expanding

No providers currently list Klotho. Get notified when one does, or explore providers carrying similar peptides in the Longevity category.

Questions to ask your provider

Stay updated on Klotho providers

New providers added weekly — delivered to your inbox.

Weekly research digest. No spam. Unsubscribe anytime.

Last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.